Drug intelligence / Profile preview

quercetin-7-isopropyl

Development stage
Preclinical
Lead developer
Centre National de la Recherche Scientifique
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

quercetin-7-isopropyl (7-O-isopropylquercetin) is a semi-synthetic alkylated derivative of the natural flavonoid quercetin. By substituting the hydroxyl group at the C-7 position with an isopropyl ether group, the molecule exhibits enhanced lipophilicity and potentially improved metabolic stability compared to parent quercetin. It is primarily recognized for its anti-carbonyl and oxidative stress (anti-COS) properties, specifically its ability to protect neuronal cells from carbonyl stress induced by toxic aldehydes such as acrolein. This compound is also a critical structural component and synthetic intermediate for polyunsaturated lipophenols, such as quercetin-3-docosahexaenoic acid-7-isopropyl, which are being developed as multifunctional agents for neurodegenerative disorders like Alzheimer's disease. Research conducted by the CNRS and the University of Montpellier has highlighted its potential in alleviating harmful mechanisms associated with neuronal cell loss.

Other names
7-O-isopropylquercetin7-isopropylquercetin7-iPr-quercetin7-isopropyl quercetin

Beyond the preview

Go deeper on quercetin-7-isopropyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on quercetin-7-isopropyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call